Concentrix Corporation (CNXC) Earnings: Q3 Fiscal 2026 Results and Next Report Date

The quarter ended August 31, 2026 and Concentrix published the results on September 29, 2026. Revenue and diluted EPS are shown against Q3 fiscal 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. Concentrix reports EPS two ways: GAAP, under the accounting rules every US filer follows, and non-GAAP, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Concentrix's fiscal year ends on November 30. Q3 fiscal 2026 is the three months ended August 31, 2026.
• The GAAP loss includes a non-cash goodwill impairment charge of $1,050.0 million, which Concentrix attributed mainly to the trading range of its stock price and market capitalization. It recorded a $1,523.3 million goodwill impairment in Q4 fiscal 2025 for the same reason.
• Vertical revenue is shown in millions rounded from the thousands Concentrix reports, so the year-ago rows add to $2,483.2 million against a reported total of $2,483.3 million.

Source: Concentrix Q3 fiscal 2026 results, September 29, 2026. Also in the Form 10-Q for the quarter ended August 31, 2026. Figures as reported; checked against the release on November 10, 2026.

How Concentrix splits revenue in its own release, under its own labels, for Q3 fiscal 2026 against Q3 fiscal 2025. Indented lines are parts of the line above them.

• Concentrix's Technology and consumer electronics revenue was $604 million in Q3 fiscal 2026, down 10% from $671 million in Q3 fiscal 2025, 25% of total revenue.
• Concentrix's Retail, travel and e-commerce revenue was $663 million in Q3 fiscal 2026, up 6% from $623 million in Q3 fiscal 2025, 27% of total revenue.
• Concentrix's Communications and media revenue was $382 million in Q3 fiscal 2026, down 7% from $411 million in Q3 fiscal 2025, 16% of total revenue.
• Concentrix's Banking, financial services and insurance revenue was $433 million in Q3 fiscal 2026, up 13% from $384 million in Q3 fiscal 2025, 18% of total revenue.
• Concentrix's Healthcare revenue was $145 million in Q3 fiscal 2026, down 17% from $174 million in Q3 fiscal 2025, 6% of total revenue.
• Concentrix's Other revenue was $228 million in Q3 fiscal 2026, up 4% from $220 million in Q3 fiscal 2025, 9% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

In its Q3 fiscal 2026 release, Concentrix said:

“Fourth quarter reported revenue of $2.410 billion to $2.460 billion.”

“Operating income of $174 million to $184 million and non-GAAP operating income of $310 million to $320 million.”

“Non-GAAP diluted EPS of $2.86 to $2.98, assuming approximately 61.2 million diluted common shares outstanding and approximately 4.9% of net income attributable to participating securities.”

“Full year reported revenue of $9.827 billion to $9.877 billion.”

Source: Concentrix Q3 fiscal 2026 release, Sep 29, 2026.

This is the company's own guidance as of Sep 29, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the CNXC forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP revenue and diluted EPS, each as first reported in that quarter's release. The losses in Q4 fiscal 2025 and Q3 fiscal 2026 come from non-cash goodwill impairment charges of $1,523.3 million and $1,050.0 million.

Concentrix's next report is expected around January 13, 2027, a date estimated from its reporting history that the company has not yet confirmed. This page will show Q3 fiscal 2026 until those results are out and have been checked against the release.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 fiscal 2026 (this page), reported Sep 29, 2026

Concentrix reported Q3 fiscal 2026 revenue of $2,453.7 million, down 1.2% from $2,483.3 million a year earlier and down 0.5% in constant currency. Concentrix designs, builds and runs customer experience operations for more than 2,000 clients, combining staff with AI tools, and its 10-K describes a team of approximately 455,000 employees and staff in 74 countries. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026; Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026; Concentrix Form 10-K, fiscal 2025, Jan 28, 2026)

Concentrix reports revenue by the industry its clients are in. In Q3 fiscal 2026 banking, financial services and insurance grew 12.5% and retail, travel and e-commerce grew 6.4%, both on increases from several of their largest clients. Technology and consumer electronics fell 10.0%, communications and media 7.1% and healthcare 16.6%, which Concentrix attributed to lower revenue from larger clients in each. (Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026)

Concentrix's revenue is concentrated: its five largest clients represented approximately 19% of revenue in fiscal 2025. Most of the work is delivered abroad, with approximately 89% of fiscal 2025 revenue generated by non-U.S. operations and a significant presence in the Philippines and India. (Concentrix Form 10-K, fiscal 2025, Jan 28, 2026)

Concentrix CEO Chris Caldwell said 50% of revenue now comes from business won and deployed in the last 3 years. Concentrix also agreed in February 2026 to sell a non-core business for approximately 15 million euros, and expects that sale to close in the fourth quarter of fiscal 2026. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026; Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026)

Concentrix's GAAP diluted loss per share was $16.24 in Q3 fiscal 2026, against earnings of $1.34 a year earlier, because of a non-cash goodwill impairment charge of $1,050.0 million. Concentrix said it ran the impairment test after a sustained fall in its stock price left its market capitalization well below the carrying value of its single reporting unit. The impairment accounts for $17.24 of the per-share gap to non-GAAP diluted EPS of $2.92. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026; Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026)

Concentrix's non-GAAP EPS also excludes amortization of intangibles ($1.66 a share), acquisition-related, integration and restructuring expenses ($0.70) and share-based compensation ($0.36). Restructuring included severance of $31.4 million in the quarter from cost reduction initiatives that affected approximately 30,000 employees. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026; Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026)

Diluted shares were 60,910 thousand, against 62,702 thousand a year earlier. Concentrix bought back no shares in Q3 fiscal 2026, after repurchasing 1,081 thousand shares for $43.2 million earlier in the fiscal year, and had $396.6 million of repurchase authorization left. It raised its quarterly dividend to $0.37 per share from $0.36. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026; Concentrix Form 10-Q, Q3 fiscal 2026, Oct 7, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

Concentrix gives a numeric outlook in its release. For Q4 fiscal 2026 it expects revenue of $2.410 billion to $2.460 billion, a constant currency decline of 3.0% to 5.0%, operating income of $174 million to $184 million and non-GAAP diluted EPS of $2.86 to $2.98. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026)

For the full fiscal year 2026, Concentrix expects revenue of $9.827 billion to $9.877 billion, non-GAAP diluted EPS of $10.97 to $11.09, an effective tax rate of approximately 24% and adjusted free cash flow of approximately $630.0 million to $650.0 million. (Concentrix Q3 fiscal 2026 release, Sep 29, 2026)

A consensus figure is the average of the models published by the analysts who cover Concentrix, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones Concentrix's own release and filings put weight on for Q3 fiscal 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning CNXC is on is CNXC a buy or a sell?, what analysts expect next is on the CNXC forecast, and what the company does is on the Concentrix Corporation (CNXC) stock page.

Every number on this page can be traced to a document Concentrix published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.